(Q35668415)

9 August 2017

1 reference

title

Antitumor activity of sugar-modified cytosine nucleosides (English)

1 reference

9 August 2017

0 references

Akira Matsuda

1

1 reference

9 August 2017

Takuma Sasaki

series ordinal

2

1 reference

9 August 2017

publication date

1 February 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

95

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

105-111

1 reference

Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Gemcitabine-based therapy in pancreas cancer: gemcitabine-docetaxel and other novel combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Mammalian deoxyribonucleoside kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Structure and function of cellular deoxyribonucleoside kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Antimetabolite incorporation into DNA: structural and thermodynamic basis for anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

A novel affinity chromatography method for the co-purification of deoxycytidine kinase and cytidine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Model of chemotherapy-induced myelosuppression with parameter consistency across drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Antitumor activity and pharmacokinetics of TAS-106, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03189.X

10.1111/J.1349-7006.2004.TB03189.X

21 January 2018

Identifiers

DOI

1 reference

release_uibrypxurvfsnptxvbnf5enari

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uibrypxurvfsnptxvbnf5enari

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference